Uncategorized

Zepbound (Tirzepatide) Gets FDA Approval for Sleep Apnea Patients

Eli Lilly said the Food and Drug Administration approved Zepbound (Tirzepatide) for moderate-to-severe obstructive sleep apnea in adults with obesity. Zepbound, or tirzepatide, is the first and only prescription medicine for adults with sleep apnea. The drug is already approved treatment of adults with obesity or who are overweight with weight-related comorbidities. Obstructive sleep apnea […]

Zepbound (Tirzepatide) Gets FDA Approval for Sleep Apnea Patients Read More »

Scroll to Top